BAT Malaysia Reports 5.6% Q2 Revenue Decline: Profits Hit by Vuse Investments

BAT by 2FIRSTS.ai
Jul.24.2024
BAT Malaysia Reports 5.6% Q2 Revenue Decline: Profits Hit by Vuse Investments
British American Tobacco (BAT) Malaysia announced a 5.6% drop in Q2 revenue, reaching 640 million Malaysian Ringgit.

According to Market Screener's report on July 24th, British American Tobacco Malaysia announced its financial performance for the Q2 quarter ending June 30, 2024.

 

The company's revenue for the second quarter was 640 million Malaysian Ringgit (137 million US dollars), a decrease of 5.6% from the same period last year. This quarter's operating profit was 56 million Ringgit (11.99 million US dollars), down from 73 million Ringgit (15.63 million US dollars) a year ago, as a result of continued investment in the e-cigarette brand Vuse.

 

The cigarette brand Dunhill continues to solidify its market leadership position in Malaysia, with its market share increasing by 0.4% from the previous quarter to reach 30.9%. Despite the ongoing impact of consumers shifting to e-cigarettes and traditional tobacco products, its performance remains strong. Compared to the previous quarter, the market share of its high-end brand decreased by 0.2% to 6.0%, while the market share of its value-for-money brand remained unchanged at 12.7%.

 

In the review of the past six months, BAT Malaysia's overall sales have decreased compared to the first half of 2023, due to a sluggish market in the first quarter of 2024. However, there was a rebound in sales in the second quarter of 2024, indicating a gradual recovery. Additionally, due to investments in Vuse e-cigarette and an increase in operating expenses, the company's operating profit decreased by 22.3% to 102 million ringgit (21.84 million USD).

 

BAT Malaysia's board of directors announced a second interim dividend of 12 sen per ordinary share, totaling RM 34.2 million (USD 7.32 million), to be paid to shareholders on August 22, 2024.

 

Nedal Salem, the Managing Director of BAT Malaysia, stated that...

 

Our financial performance met expectations as we continued to invest in developing Vuse in Malaysia. Our goal is to build a better tomorrow, and the group firmly believes that its strategic investments will contribute to achieving sustainable growth in Malaysia.

 

The tobacco black market continues to impact the industry, with its occurrence rate still at 54.8%. While the group applauds law enforcement agencies' efforts to crack down on the illicit tobacco trade, they believe the government should consider reviewing its tax policies in order to align with the strengthened enforcement measures expected in the upcoming 2025 budget.

 

The group believes that the "2024 Public Health Tobacco Control Law" is the right direction for the industry. Any regulations introduced must be reasonable and evidence-based to ensure effective implementation and achieve the intended goals, without promoting the growth of the tobacco or e-cigarette black market.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts Data | China’s Vape Exports Rise 3.1% in H1 2026 as 6-Methyl Nicotine-Related Products Surge 65.2%
2Firsts Data | China’s Vape Exports Rise 3.1% in H1 2026 as 6-Methyl Nicotine-Related Products Surge 65.2%
China’s vape exports showed resilience in the first half of 2026 after a short-term shock from China’s export rebate adjustment. But customs data points to more than a simple recovery: the structure of growth is changing. Vaping devices and atomization hardware emerged as the strongest growth driver, while nicotine-containing vaping products remained broadly stable. Meanwhile, nicotine substitute-related products represented by 6-methyl nicotine expanded rapidly, becoming a new category to watch for both industry and regulators. After the U.S. market went through a cycle of shortages, replenishment and inventory rebuilding in 2025, China’s vape supply chain is entering a new phase of reallocation.
Special Report
Jul.20
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
Bret Koplow, acting director of the U.S. Food and Drug Administration's Center for Tobacco Products, will deliver a keynote and participate in a fireside chat at the National Association of Tobacco Outlets' Sept. 29-30 conference in Washington. His appearance comes months after the FDA moved to accelerate PMTA reviews and introduced a more differentiated enforcement policy for certain unauthorized ENDS and oral nicotine pouch products. The agency also plans a public list identifying manufacturers and products it does not currently intend to prioritize for enforcement under the May guidance. NATO says its membership includes more than 66,000 retail stores, making product-status transparency and enforcement boundaries directly relevant to the retail sector.
Aug.14
UK HMRC Urges Public to Report Suspicious Vape Shops in Crackdown on Tax Fraud, Money Laundering and Illicit Tobacco Sales
UK HMRC Urges Public to Report Suspicious Vape Shops in Crackdown on Tax Fraud, Money Laundering and Illicit Tobacco Sales
HM Revenue & Customs is urging members of the public to report vape shops, barber shops and other high-street businesses suspected of tax fraud, money laundering or other illegal activity, with informants not required to provide personal details. HMRC plans more than 30,000 interventions in 2026-27 targeting tax fraud, organised crime and illicit activity, including the sale of illegal vapes and tobacco. The push forms part of a broader UK effort to tackle organised crime on high streets, backed by a £30 million government enforcement programme.
Regulations
Aug.17 by 2Firsts Perspectives
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
UK Reform Party Proposes Cap of 1,000 Vape Shops Under Plan to Tighten Retail Controls
UK Reform Party Proposes Cap of 1,000 Vape Shops Under Plan to Tighten Retail Controls
The UK Reform Party has proposed limiting the number of dedicated vape shops in the country to around 1,000 as part of a plan to tighten oversight of vape retail channels. The proposal was put forward by Reform UK deputy leader and MP Lee Anderson. The plan remains a political proposal and has not become UK government policy, with no detailed legislation, implementation timeline or allocation rules announced.
Aug.10
 PMI Opens Generative AI Center in Portugal to Support Global Operations
PMI Opens Generative AI Center in Portugal to Support Global Operations
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has established a global Generative Artificial Intelligence Factory (GenAI Factory) at its Portuguese subsidiary Tabaqueira. The center will support PMI’s global operations by developing and deploying AI solutions focused on industrial process optimization, data analytics, operational automation and AI application development. The initiative strengthens Portugal’s role in PMI’s global technology and innovation network.
Aug.27